Sysmex RDCA is endeavoring to create new clinical value for personalized medicine through open innovation – generating synergy by combining the technology and knowledge possessed by universities and research institutes with our own.

Our R&D Activities Through Open Innovation Include:

Research and Development of applications in a variety of disease fields using our technology platforms such as for genes, cells and proteins.

Disease Fields

  • Cancer
  • Chronic Disease
  • Infectious Disease
  • Immunological Disease
  • Cardiovascular Disease
  • Blood

Gene Measurement Technolgies

Gene analysis technologies for personalized medicine, such as prediction of onset, recurrence risk and therapeutic efficacy.

Learn More >

Cell Measurement Technologies

Technologies to detect and analyze the characteristics of rare and abnormal cells in the blood.

Learn More >

Protein Measurement Technologies

Protein analysis technologies for medical treatment and early detection of infectious diseases, cancer and heart diseases.

Learn More >

R&D of elemental technologies in the area such as biology, chemistry, information science, electronic engineering etc.

Knowledge Underpinning R&D

Medical Engineering

Information Science

Electronic Engineering

Chemistry

Applied Physics

Biology